Singh N, Madhira V, Hu C, Olex AL, Bergquist T, Fitzgerald KC, Huling JD, Patel RC, Singh JA. Rituximab is associated with worse COVID-19 outcomes in patients with rheumatoid arthritis: A retrospective, nationally sampled cohort study from the U.S. National COVID Cohort Collaborative (N3C). Semin Arthritis Rheum. 2022 Dec 8;58:152149. doi: 10.1016/j.semarthrit.2022.152149. Epub ahead of print. PMID: 36516563; PMCID: PMC9729169.